Journal of controlled release : official journal of the Controlled Release Society

Designing lipid nanoparticles from their molecular makeup to how they work in living systems

Updated

Abstract

The 2023 Nobel Prize recognized the role of base modifications in advancing effective mRNA vaccines.

  • Modern drug delivery technologies have been crucial for the success of RNA-based medicines.
  • Lipid nanoparticles (LNPs) have enabled the clinical application of these therapies in less than a decade.
  • Challenges in LNP design arise from complex interactions between lipids and RNA, as well as biological barriers.
  • Understanding how protein corona formation affects in vivo performance is essential for LNP effectiveness.
  • State-of-the-art strategies for LNP development include computational design and high-throughput screening.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of competing interest BW has equity interests in RNhale GmbH. MJA has equity interests in Libera Bio. The authors declare no other competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free